Transitional Basal Cells at the Squamous-columnar Junction Generate Barrett's Oesophagus
Authors
Affiliations
In several organ systems, the transitional zone between different types of epithelium is a hotspot for pre-neoplastic metaplasia and malignancy, but the cells of origin for these metaplastic epithelia and subsequent malignancies remain unknown. In the case of Barrett's oesophagus, intestinal metaplasia occurs at the gastro-oesophageal junction, where stratified squamous epithelium transitions into simple columnar cells. On the basis of a number of experimental models, several alternative cell types have been proposed as the source of this metaplasia but in all cases the evidence is inconclusive: no model completely mimics Barrett's oesophagus in terms of the presence of intestinal goblet cells. Here we describe a transitional columnar epithelium with distinct basal progenitor cells (p63KRT5KRT7) at the squamous-columnar junction of the upper gastrointestinal tract in a mouse model. We use multiple models and lineage tracing strategies to show that this squamous-columnar junction basal cell population serves as a source of progenitors for the transitional epithelium. On ectopic expression of CDX2, these transitional basal progenitors differentiate into intestinal-like epithelium (including goblet cells) and thereby reproduce Barrett's metaplasia. A similar transitional columnar epithelium is present at the transitional zones of other mouse tissues (including the anorectal junction) as well as in the gastro-oesophageal junction in the human gut. Acid reflux-induced oesophagitis and the multilayered epithelium (believed to be a precursor of Barrett's oesophagus) are both characterized by the expansion of the transitional basal progenitor cells. Our findings reveal a previously unidentified transitional zone in the epithelium of the upper gastrointestinal tract and provide evidence that the p63KRT5KRT7 basal cells in this zone are the cells of origin for multi-layered epithelium and Barrett's oesophagus.
Unraveling the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma: the "omics" era.
Barchi A, DellAnna G, Massimino L, Mandarino F, Vespa E, Viale E Front Oncol. 2025; 14:1458138.
PMID: 39950103 PMC: 11821489. DOI: 10.3389/fonc.2024.1458138.
RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition.
Fang Y, Chung S, Xu L, Xue C, Liu X, Jiang D Nature. 2025; .
PMID: 39910313 DOI: 10.1038/s41586-024-08542-2.
Kobayashi M, Usui T, Elbadawy M, Kigata T, Kaneda M, Murakami T Int J Mol Sci. 2024; 25(23).
PMID: 39684417 PMC: 11640979. DOI: 10.3390/ijms252312706.
Breaking the mold: 3D cell cultures reshaping the future of cancer research.
Cordeiro S, Oliveira B, Valente R, Ferreira D, Luz A, Baptista P Front Cell Dev Biol. 2024; 12:1507388.
PMID: 39659521 PMC: 11628512. DOI: 10.3389/fcell.2024.1507388.
Esophageal adenocarcinoma models: a closer look.
Bhat N, Al-Mathkour M, Maacha S, Lu H, El-Rifai W, Ballout F Front Mol Biosci. 2024; 11:1440670.
PMID: 39600303 PMC: 11589788. DOI: 10.3389/fmolb.2024.1440670.